Ciclosporin/immune globulinHypertension, hyperkalaemia and no response: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1957卷 / 1期

关键词：

D O I：

10.1007/s40278-023-39273-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：148 / 148

相关论文

共 50 条

[1] Ciclosporin/tacrolimusHyporeninaemic hypoaldosteronism leading to hyperkalaemia: 2 case reports
[J]. Reactions Weekly, 2022, 1895 (1) : 133 - 133
[2] Ciclosporin/tacrolimusEncephalopathy: 6 case reports
[J]. Reactions Weekly, 2009, 1244 (1) : 13 - 13
[3] ThalidomideFirst report of hyperkalaemia: 6 case reports
[J]. Reactions Weekly, 2003, 975 (1) : 14 - 14
[4] Immune-globulinHypertension and injection-site thrombophlebitis: 2 case reports
[J]. Reactions Weekly, 2019, 1757 (1) : 163 - 163
[5] Immune-globulinHypertension: case report
[J]. Reactions Weekly, 2015, 1552 (1) : 131 - 131
[6] Ciclosporin/tacrolimusNo response: 2 case reports
[J]. Reactions Weekly, 2022, 1922 (1) : 178 - 178
[7] Ciclosporin/immune globulin/prednisoneLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2021, 1864 (1) : 108 - 108
[8] Furosemide/hydrochlorothiazide/amilorideNo response and hyperkalaemia: 2 case reports
[J]. Reactions Weekly, 2023, 1973 (1) : 129 - 129
[9] Ciclosporin/methylprednisoloneVarious toxicities in paediatric patients: 6 case reports
[J]. Reactions Weekly, 2012, 1425 (1) : 13 - 13
[10] Ciclosporin/immune-globulinNo response: case report
[J]. Reactions Weekly, 2021, 1853 (1) : 127 - 127

← 1 2 3 4 5 →